The delivery will be used to immunize 110 million people and will be done once the World Health Organization (WHO) authorizes its emergency use, a decision expected to be made soon, taking into account that the request was submitted in October 2020.
The agreement with UNICEF on the provision of Sputnik V will expand the access to aid to meet the vaccine demand across the globe.
Kirill Dmitriev, RDIF CEO, said they are proud to support UNICEF and its partners’ global efforts to ensure all countries’ equitable and broad access to Covid-19 vaccines.
He added that vaccination is the best way to defeat the pandemic, help other people to feel safe, restore economies and go back to normal.
At the same time, RDIF informed that it will also hold talks with the Vaccine Alliance (GAVI), so that the inclusion of the Russian vaccine in the portfolio of drugs against the pandemic of the international Covax program will be considered.
This platform promotes global collaboration to speed up the development and production of vaccines against the coronavirus and guarantee that all countries have just and equitable access to them, regardless their income level.
Covax is co-directed by the Coalition for Epidemic Preparedness Innovations, Gavi and WHO.
The mechanism aims to create a diversified vaccine portfolio and distribute at least 2 billion doses by the end of 2021, including a minimum of 1.3 billion for 92 low-income countries.